#1 Clinical Trials Search in Europe

Orlistat

This article examines the use of orlistat, a medication used for weight loss, in various clinical trials. Orlistat works by inhibiting fat absorption in the intestines. The trials discussed here investigate orlistat’s effectiveness for weight loss maintenance, its impact on uric acid levels, its potential use in rare metabolic disorders, and its safety profile. We’ll explore how orlistat compares to other formulations and its effects on different patient populations.

Table of Contents

What is Orlistat?

Orlistat is a medication primarily used for weight loss in overweight and obese individuals. It’s available under different brand names, including Xenical (prescription strength) and Alli (over-the-counter strength)[1]. Orlistat is designed to work alongside a reduced-calorie diet and regular exercise to help patients achieve and maintain a healthy weight[2].

How Orlistat Works

Orlistat functions as a gastric and pancreatic lipase inhibitor. In simpler terms, it blocks enzymes in your digestive system that break down fats. By doing this, Orlistat reduces the amount of fat your body absorbs from the food you eat[1]. This leads to fewer calories being absorbed, which can help with weight loss.

The medication works locally in your digestive tract and is not significantly absorbed into your bloodstream. This means it primarily affects fat digestion in your intestines without having widespread effects throughout your body[3].

Conditions Treated with Orlistat

Orlistat is primarily used to treat:

  • Obesity: It helps overweight or obese individuals lose weight and maintain weight loss[4].
  • Type 2 Diabetes: In some cases, it may be used as part of a treatment plan for type 2 diabetes, especially when associated with obesity[2].
  • Hyperuricemia: Recent research is exploring its potential to reduce uric acid levels in overweight or obese patients with high uric acid levels[5].
  • Hyperlipoproteinemia Type I: This is a rare genetic disorder characterized by extremely high levels of triglycerides in the blood. Orlistat is being studied as a potential treatment for this condition[1].

Dosage and Administration

Orlistat is typically taken as a capsule with meals. The dosage can vary depending on the specific formulation and the patient’s needs:

  • Xenical (prescription strength): Usually 120 mg taken three times daily with each main meal containing fat[2].
  • Alli (over-the-counter strength): Usually 60 mg taken three times daily with each main meal containing fat[6].

It’s important to take Orlistat with meals that contain some fat, but it’s also crucial to follow a reduced-calorie, low-fat diet while using this medication. If you eat a meal without fat, you can skip the dose for that meal[2].

Effectiveness of Orlistat

Studies have shown that Orlistat can be effective for weight loss when used in combination with a reduced-calorie diet and exercise. It typically helps people lose about 5-10% of their body weight over a period of 1-4 years[4]. However, the effectiveness can vary from person to person.

In addition to weight loss, Orlistat may have other health benefits. For example, it’s being studied for its potential to reduce uric acid levels in people with hyperuricemia (high uric acid levels in the blood)[5]. It’s also being investigated as a potential treatment for a rare genetic disorder called Type I Hyperlipoproteinemia, which causes extremely high levels of triglycerides in the blood[1].

Potential Side Effects

Like all medications, Orlistat can cause side effects. The most common side effects are related to its mechanism of action in the digestive system and can include:

  • Oily or fatty stools
  • Increased bowel movements
  • Gas with oily discharge
  • Difficulty controlling bowel movements

These side effects are usually mild and tend to decrease over time as you adjust to the medication and follow a low-fat diet[2].

In rare cases, more serious side effects can occur. There have been some reports of liver problems in people taking Orlistat, although a direct causal relationship has not been established. Regular monitoring of liver function may be recommended while taking this medication[6].

Ongoing Research

Researchers continue to study Orlistat to better understand its effects and potential uses. Some areas of ongoing research include:

  • Its potential to reduce uric acid levels in overweight or obese patients with hyperuricemia[5].
  • Its use in treating Type I Hyperlipoproteinemia, a rare genetic disorder that causes extremely high triglyceride levels[1].
  • The development of new formulations of Orlistat, such as EMP22 and EMP16, which are being studied for their pharmacodynamic and pharmacokinetic properties[7].

These ongoing studies may lead to new uses for Orlistat or improvements in its formulation and administration in the future.

Study Focus Key Findings Patient Population Duration
Weight Loss Maintenance Orlistat used intermittently for up to 4 years to maintain weight loss Obese adults 4 years
Uric Acid Reduction Orlistat’s effect on reducing uric acid levels in overweight/obese patients with hyperuricemia Overweight/obese with hyperuricemia 12 weeks
Type I Hyperlipoproteinemia Treatment Investigating orlistat’s efficacy in reducing triglyceride levels in a rare metabolic disorder Patients with Type I Hyperlipoproteinemia 3 months
Liver Function Safety Meta-analysis of liver function data to assess potential liver toxicity Participants from various orlistat trials Up to 1 year
New Formulation Comparison Comparing pharmacodynamics of new orlistat formulations (EMP22, EMP16) with Xenical Healthy volunteers 9-13 weeks

FAQ

  • What is orlistat and how does it work? Orlistat is a medication used for weight loss. It works by inhibiting gastric and pancreatic lipases in the gastrointestinal tract, which reduces the absorption of dietary fat.
  • What are the common brand names for orlistat? Common brand names for orlistat include Xenical (120 mg prescription strength) and Alli (60 mg over-the-counter strength).
  • How is orlistat typically administered? Orlistat is usually taken as a 120 mg capsule three times daily with meals, or within one hour after meals.
  • Can orlistat help with conditions other than obesity? Some trials are investigating orlistat's potential benefits for other conditions, such as hyperuricemia (high uric acid levels) and rare metabolic disorders like Type I Hyperlipoproteinemia.
  • What are some common outcomes measured in orlistat clinical trials? Common outcomes include changes in body weight, body mass index (BMI), waist circumference, fecal fat excretion, and various blood markers such as lipid levels and liver function tests.

Ongoing Clinical Trials on Orlistat

  • Orlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study on the Effects of EMP16 and Ispaghula Husk for Obesity in Adults

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study on Orlistat’s Effect on Liver Fat in Obese Patients with Non-Alcoholic Fatty Liver Disease and High Proneurotensin Levels

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Sweden

Glossary

  • Orlistat: A medication that inhibits fat absorption in the intestines, used for weight loss in overweight or obese individuals.
  • Body Mass Index (BMI): A measure of body fat based on height and weight, used to determine if a person is overweight or obese.
  • Hyperuricemia: A condition characterized by high levels of uric acid in the blood, which can lead to gout and kidney problems.
  • Type I Hyperlipoproteinemia: A rare genetic disorder characterized by extremely high levels of triglycerides in the blood, which can lead to recurrent pancreatitis.
  • Pharmacodynamics (PD): The study of how a drug affects the body, including its mechanism of action and biochemical effects.
  • Pharmacokinetics (PK): The study of how the body processes a drug, including its absorption, distribution, metabolism, and excretion.
  • Fecal Fat Excretion: The amount of fat excreted in feces, which can be used to measure the effectiveness of orlistat in blocking fat absorption.
  • Lipase: An enzyme that breaks down fats in the digestive system. Orlistat works by inhibiting lipases.
  • Triglycerides: A type of fat found in the blood. High levels of triglycerides can increase the risk of heart disease and pancreatitis.
  • Chylomicronemia: A condition characterized by high levels of chylomicrons (large fat particles) in the blood, often seen in Type I Hyperlipoproteinemia.

References

  1. https://clinicaltrials.gov/study/NCT02767531
  2. https://clinicaltrials.gov/study/NCT01597531
  3. https://clinicaltrials.gov/study/NCT01797757
  4. https://clinicaltrials.gov/study/NCT02706067
  5. https://clinicaltrials.gov/study/NCT05496075
  6. https://clinicaltrials.gov/study/NCT01332448
  7. https://clinicaltrials.gov/study/NCT06013163